NCT06926920
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06926920
Title A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Gilead Sciences
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Los Angeles Cancer Network (LACN) - Good Sam RECRUITING Los Angeles California 90017 United States Details
Winship Cancer Institute - Emory University RECRUITING Atlanta Georgia 30322 United States Details
Siteman Cancer Center RECRUITING St Louis Missouri 63110 United States Details
West Cancer Centre RECRUITING Germantown Tennessee 38138 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
Tennessee Oncology, PLLC RECRUITING Nashville Tennessee 37203 United States Details
Texas Oncology - DFW RECRUITING Dallas Texas 75246 United States Details
Virginia Oncology Associates RECRUITING Norfolk Virginia 23502 United States Details
St. Vincent's Hospital - Kinghorn Cancer Center RECRUITING Darlinghurst New South Wales 2010 Australia Details
Sunshine Coast University Private Hospital RECRUITING Birtinya Queensland 4575 Australia Details
John Flynn Private Hospital RECRUITING Tugun Queensland 4224 Australia Details
Seoul National University Hospital RECRUITING Seoul 03080 South Korea Details
Severance Hospital, Yonsei University Health System NOT_YET_RECRUITING Seoul 03722 South Korea Details
Asan Medical Center RECRUITING Seoul 05505 South Korea Details
Samsung Medical Center RECRUITING Seoul 06351 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field